Atlas Trials

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

Clinical trial NCT00681343 · COMPLETED

Trial details

NCT number
NCT00681343
Sponsor
University of Miami
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Living-Donor Kidney Transplant
Start date
2002-09-01
Primary completion
2006-10-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.